Mutual of America Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mutual of America Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.61M	Sell	23,261 -25	-0.1%	-$5.48K	0.05%	395
2026 Q1	$4.4M	Sell	23,286 -2,004	-8%	-$350K	0.05%	449
2025 Q4	$4.3M	Sell	25,290 -2,725	-10%	-$418K	0.05%	486
2025 Q3	$3.69M	Sell	28,015 -2,635	-9%	-$316K	0.04%	554
2025 Q2	$3.25M	Sell	30,650 -464	-1%	-$50.4K	0.04%	625
2025 Q1	$3.86M	Sell	31,114 -821	-3%	-$107K	0.04%	533
2024 Q4	$3.93M	Sell	31,935 -1,442	-4%	-$170K	0.04%	564
2024 Q3	$3.72M	Sell	33,377 -2,717	-8%	-$298K	0.04%	622
2024 Q2	$3.85M	Sell	36,094 -1,418	-4%	-$156K	0.04%	576
2024 Q1	$4.52M	Sell	37,512 -1,383	-4%	-$169K	0.05%	526
2023 Q4	$4.78M	Sell	38,895 -2,138	-5%	-$267K	0.06%	469
2023 Q3	$5.31M	Sell	41,033 -5,590	-12%	-$745K	0.07%	360
2023 Q2	$5.78M	Sell	46,623 -4,023	-8%	-$541K	0.07%	378
2023 Q1	$7.41M	Sell	50,646 -1,061	-2%	-$157K	0.09%	247
2022 Q4	$8.24M	Buy	+51,707	New	+$7.58M	0.1%	215

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mutual of America Capital Management's JAZZ Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.11% in Q2 2026, selling an estimated $5.48K and leaving 23,261 shares worth $5.61M. The position accounts for 0.05% of the portfolio, ranked #395.

Mutual of America Capital Management first reported a position in JAZZ in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.24M in Q4 2022. 420 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Mutual of America Capital Management held 23,261 shares of Jazz Pharmaceuticals worth $5.61M as of Q2 2026.
Mutual of America Capital Management sold 25 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.48K.
Jazz Pharmaceuticals made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #395 holding.
Mutual of America Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
Mutual of America Capital Management's Jazz Pharmaceuticals position peaked at $8.24M in Q4 2022.
420 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.